Cargando…

2′-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With Bifidobacterium lactis: A Randomized Controlled Trial

Human milk oligosaccharides are important components of breast milk. We evaluated feeding tolerance of the human milk oligosaccharide 2′-fucosyllactose (2′FL) in a 100% whey, partially hydrolyzed infant formula with the probiotic Bifidobacterium animalis ssp lactis strain Bb12 (B lactis; Test) as co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Storm, Heidi M., Shepard, Julie, Czerkies, Laura M., Kineman, Brian, Cohen, Sarah S., Reichert, Heidi, Carvalho, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421602/ https://www.ncbi.nlm.nih.gov/pubmed/30906817 http://dx.doi.org/10.1177/2333794X19833995

Ejemplares similares

A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas
por: Czerkies, Laura A., et al.
Publicado: (2018)

A Randomized Controlled Trial Assessing Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula Compared With a Casein-Based Extensively Hydrolyzed Formula
por: Fields, David, et al.
Publicado: (2016)

A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis
por: Szajewska, Hania, et al.
Publicado: (2017)

Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides
por: Nowak-Wegrzyn, Anna, et al.
Publicado: (2019)

Peptide Characterization and Functional Stability of a Partially Hydrolyzed Whey-Based Formula over Time
por: Bourdeau, Tristan, et al.
Publicado: (2021)

A partially hydrolyzed whey formula provides adequate nutrition in high-risk infants for allergy
por: Yang, Jiyeon, et al.
Publicado: (2022)

Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense
por: Bunesova, Vera, et al.
Publicado: (2016)

Characterization of an extensively hydrolyzed whey infant formula with a low bitterness
por: Rapp, M, et al.
Publicado: (2013)

Allergenicity of partially hydrolyzed whey and casein formulas evaluated by ImmunoCAP inhibition assay and basophil activation test
por: Matsubara, Takeshi, et al.
Publicado: (2023)

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infants
por: Wallingford, John C., et al.
Publicado: (2022)

A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial
por: Karaglani, Eva, et al.
Publicado: (2020)

Assessment of Growth of Infants Fed an Amino Acid-Based Formula
por: Corkins, Mark, et al.
Publicado: (2016)

An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial
por: Picaud, Jean-Charles, et al.
Publicado: (2020)

Hypoallergenicity assessment of an extensively hydrolyzed whey‐protein formula in cow’s milk allergic infants
por: Dahdah, Lamia, et al.
Publicado: (2022)

Effects of Bifidobacterium with the Ability of 2′-Fucosyllactose Utilization on Intestinal Microecology of Mice
por: Mao, Bingyong, et al.
Publicado: (2022)

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
por: Zabel, Bryan E., et al.
Publicado: (2020)

Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2′-FL Fucosyllactose (2′-FL) Human Milk Oligosaccharide
por: Ramirez-Farias, Carlett, et al.
Publicado: (2021)

A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life
por: Billeaud, Claude, et al.
Publicado: (2022)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants
por: Vandenplas, Yvan, et al.
Publicado: (2019)

Evaluation of 2’-Fucosyllactose and Bifidobacterium longum Subspecies infantis on Growth, Organ Weights, and Intestinal Development of Piglets
por: Daniels, Victoria C., et al.
Publicado: (2021)

Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health
por: Tremblay, Annie, et al.
Publicado: (2023)

Antibacterial Activity of Trypsin-Hydrolyzed Camel and Cow Whey and Their Fractions
por: Wang, Ruixue, et al.
Publicado: (2020)

Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants
por: Berseth, Carol Lynn, et al.
Publicado: (2009)

Influence of 2′-Fucosyllactose and Bifidobacterium longum Subspecies infantis Supplementation on Cognitive and Structural Brain Development in Young Pigs
por: Sutkus, Loretta T., et al.
Publicado: (2022)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level
por: Lindner, Cordula, et al.
Publicado: (2023)

Infant microbiome cultivation and metagenomic analysis reveal Bifidobacterium 2’-fucosyllactose utilization can be facilitated by coexisting species
por: Lou, Yue Clare, et al.
Publicado: (2023)

Partially Hydrolysed Whey-Based Infant Formula Improves Skin Barrier Function
por: Holvoet, Sébastien, et al.
Publicado: (2021)

Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04
por: Andersen, Joakim M, et al.
Publicado: (2013)

Microbiology neutralization of zearalenone using Lactococcus lactis and Bifidobacterium sp.
por: Król, A., et al.
Publicado: (2017)

Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials
por: Szajewska, Hania, et al.
Publicado: (2013)

Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline
por: Morovic, Wesley, et al.
Publicado: (2018)

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
por: Uusitupa, Henna-Maria, et al.
Publicado: (2020)

Isolation and characterization of bacterial cellulose produced from soybean whey and soybean hydrolyzate
por: Liu, Xin, et al.
Publicado: (2023)

Nutrient intakes and sources of fiber among children with low and high dietary fiber intake: the 2016 feeding infants and toddlers study (FITS), a cross-sectional survey
por: Finn, Kristen, et al.
Publicado: (2019)

Short-term effect of partially hydrolyzed formula on the prevention of development of atopic dermatitis in infants at high risk.
por: Han, Young-Shin, et al.
Publicado: (2003)

Should partially hydrolyzed infant formula be given to the general infant population for the primary prevention of allergic disease?
por: Song, Tae Won
Publicado: (2019)

Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose
por: Reverri, Elizabeth J., et al.
Publicado: (2018)

Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2′-fucosyllactose
por: Zabel, Bryan, et al.
Publicado: (2019)

The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)
por: Jungersen, Mikkel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pd8n7db34ma7qo2abmovv07725